Technology developed at The University of Tulsa and licensed by FortySix Venture Capital could advance cancer testing and targeted therapeutics
TULSA, Okla., Jan. 10, 2023 /PRNewswire/ -- FortySix Venture Capital LLC (46VC) and The University of Tulsa (TU) announced today that technology developed by TU researchers has been licensed by 46VC for commercialization efforts.
- TULSA, Okla., Jan. 10, 2023 /PRNewswire/ -- FortySix Venture Capital LLC (46VC) and The University of Tulsa (TU) announced today that technology developed by TU researchers has been licensed by 46VC for commercialization efforts.
- Based on the teams' research, the technology licensed has the capability to radically change the time and expense required to target therapeutics for the deadliest forms of cancer.
- 46VC and The University of Tulsa have executed a license arrangement that will accelerate the commercialization of these technologies.
- The University of Tulsa and 46VC will begin working together to commercialize the important discovery immediately.